Redmile Biopharma Investments Iii, L.p. - Net Worth and Insider Trading
Redmile Biopharma Investments Iii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Redmile Biopharma Investments Iii, L.p. owns 2 companies in total, including Entrada Therapeutics Inc (TRDA) , and Invivyd Inc (IVVD) .
Insider Ownership Summary of Redmile Biopharma Investments Iii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRDA | Entrada Therapeutics Inc | 2021-10-28 | 10 percent owner |
| IVVD | Invivyd Inc | 2021-08-05 | 10 percent owner |
Redmile Biopharma Investments Iii, L.p. Trading Performance
Redmile Biopharma Investments Iii, L.p. Ownership Network
Redmile Biopharma Investments Iii, L.p. Owned Company Details
What does Entrada Therapeutics Inc do?
Who are the key executives at Entrada Therapeutics Inc?
Redmile Biopharma Investments Iii, L.p. is the 10 percent owner of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Scientific Officer Natarajan Sethuraman , Chief Operating Officer Nathan J Dowden , and Chief Financial Officer Kory James Wentworth .
Entrada Therapeutics Inc (TRDA) Insider Trades Summary
Over the past 18 months, Redmile Biopharma Investments Iii, L.p. made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 18,992 shares made by Dipal Doshi , a net sale of 49,989 shares made by Kory James Wentworth , and a net sale of 55,277 shares made by Nathan J Dowden .
In summary, during the past 3 months, insiders sold 40,733 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 40,733 shares. During the past 18 months, 197,159 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 151,791 shares.
Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entrada Therapeutics Inc Insider Transactions
Redmile Biopharma Investments Iii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Redmile Biopharma Investments Iii, L.p.. You might contact Redmile Biopharma Investments Iii, L.p. via mailing address: Letterman Digital Arts Center, One Letterman Drive, Suite D3-300, San Francisco Ca 94129.
Discussions on Redmile Biopharma Investments Iii, L.p.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
